Login / Signup
Bing Liu
ORCID
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 3
Top Topics
Poor Prognosis
Cell Migration
Gold Nanoparticles
Endoplasmic Reticulum Stress
Top Venues
Molecular cancer therapeutics
Cell death & disease
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Nan Fang
,
Bing Liu
,
Qiu-Zhong Pan
,
Tingting Gong
,
Meixiao Zhan
,
Jingjing Zhao
,
Qi-Jing Wang
,
Yan Tang
,
Yong-Qiang Li
,
Jia He
,
Tong Xiang
,
Fengze Sun
,
Li-Gong Lu
,
Jian-Chuan Xia
SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity.
Molecular cancer therapeutics
23 (8) (2024)
Nan Fang
,
Bing Liu
,
Qiu-Zhong Pan
,
Tingting Gong
,
Meixiao Zhan
,
Jingjing Zhao
,
Qi-Jing Wang
,
Yan Tang
,
Yong-Qiang Li
,
Jia He
,
Tong Xiang
,
Fengze Sun
,
Li-Gong Lu
,
Jian-Chuan Xia
SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity.
Molecular cancer therapeutics
(2024)
Anghui Peng
,
Xiaowen Lin
,
Quanli Yang
,
Yihao Sun
,
Ruiyan Chen
,
Bing Liu
,
Xinyang Yu
ΔNp63α facilitates proliferation and migration, and modulates the chromatin landscape in intrahepatic cholangiocarcinoma cells.
Cell death & disease
14 (11) (2023)